Prolific Investor Sees New Rice-Sized Pacemaker As ‘Game-Changer’
The technology behind the device — which converts ultrasound energy to electrical pulses that synchronize the heart’s large pumping chambers — has received the green light from the FDA.
The Mercury News:
Medical Tech Investor Allan Will Betting On Wireless Pacemaker
Among [Allan] Will’s latest ventures is EBR Systems, which develops devices for cardiac rhythm management. In September, the Sunnyvale-based company’s WiSE technology — wireless stimulation endocardially — got the greenlight from the FDA for clinical testing of its rice-sized implantable pacemaker...The wireless device converts ultrasound energy to electrical pulses that synchronize the heart’s large pumping chambers. By improving their performance, Will said, heart failure symptoms decline and mortality improves. (Seipel, 10/3)